Cerebral to pay nearly $3.7M over controlled substance prescribing practices

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Early antiplatelet medication linked to improved stroke recovery

Administering antiplatelet medication within 24 hours of mechanical thrombectomy, an effective procedure for stroke, may help patients more successfully recover and prevent high-risk individuals from

July 31, 2023

Johnson & Johnson reports 6.3% rise in Q2 2023 sales

In the pharmaceutical segment of Johnson & Johnson, a 3.1% rise in sales to $13.73bn in Q2 2023 was reported. Credit: Michael Vi / Shutterstock.com.

July 21, 2023

Can an epilepsy drug do more than reduce seizures?

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It’s the

January 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.